Sun Pharmaceutical Financials
NSE: SUNPHARMA | BSE: 524715
₹1,899.00
₹-17.00
(-0.89%)
As on 04-Sep-2026 15:59IST
Market cap
₹4,55,634 Cr
Revenue (TTM)
₹59,911 Cr
P/E Ratio
37.7
P/B Ratio
5.3
Div. Yield
0.8 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
59,910.52
|
58,462.04
|
52,578.44
|
48,496.85
|
43,885.68
|
38,654.49
|
|
|
|
|
|
|
Total Income
|
62,725.79
|
61,673.94
|
54,729.01
|
50,125.09
|
44,579.43
|
40,091.91
|
|
|
|
|
|
|
Total Expenditure
|
42,647.50
|
41,970.82
|
37,492.28
|
35,747.77
|
32,298.12
|
28,772.68
|
|
|
|
|
|
|
EBITDA
|
17,263.02
|
16,491.22
|
15,086.16
|
12,749.08
|
11,587.56
|
9,881.81
|
|
|
|
|
|
|
Depreciation
|
2,976.02
|
2,937.85
|
2,575.39
|
2,556.64
|
2,529.43
|
2,143.74
|
|
|
|
|
|
|
EBIT
|
14,287.00
|
13,553.37
|
12,510.77
|
10,192.44
|
9,058.13
|
7,738.07
|
|
|
|
|
|
|
Interest
|
363.78
|
338.91
|
231.36
|
238.47
|
172.00
|
127.35
|
|
|
|
|
|
|
Other Income
|
2,815.27
|
3,211.90
|
2,150.57
|
1,628.24
|
693.75
|
1,437.42
|
|
|
|
|
|
|
Exceptional Items
|
-693.57
|
-1,307.48
|
-677.85
|
-494.32
|
-171.45
|
-4,566.82
|
|
|
|
|
|
|
Profit before Tax
|
16,044.92
|
15,118.88
|
13,752.13
|
11,087.89
|
9,408.43
|
4,481.32
|
|
|
|
|
|
|
Provision for Tax
|
3,872.22
|
3,554.36
|
2,772.03
|
1,439.45
|
847.59
|
1,075.50
|
|
|
|
|
|
|
Profit after Tax
|
12,172.70
|
11,564.52
|
10,980.10
|
9,648.44
|
8,560.84
|
3,405.82
|
|
|
|
|
|
|
Minority Interest
|
-21.43
|
-29.23
|
-35.71
|
-33.65
|
-39.36
|
-116.55
|
|
|
|
|
|
|
Share of Associate
|
-55.69
|
-55.87
|
-15.35
|
-38.41
|
-47.90
|
-16.54
|
|
|
|
|
|
|
Consolidated Profit
|
12,095.58
|
11,479.42
|
10,929.04
|
9,576.38
|
8,473.58
|
3,272.73
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
83,570.09
|
83,570.09
|
72,218.02
|
63,666.75
|
55,995.38
|
48,011.22
|
|
|
|
|
|
|
Minority Interest
|
-21.43
|
309.65
|
267.93
|
3,459.19
|
3,320.09
|
3,054.89
|
|
|
|
|
|
|
Non-Current Liabilities
|
2,283.44
|
-1,763.02
|
-2,987.13
|
-2,714.34
|
-1,997.80
|
-1,316.37
|
|
|
|
|
|
|
Current Liabilities
|
22,622.04
|
22,622.04
|
18,194.21
|
16,983.77
|
19,906.38
|
17,208.45
|
|
|
|
|
|
|
Total Liabilities
|
1,08,785.22
|
1,08,407.20
|
91,908.14
|
85,327.79
|
80,711.90
|
69,775.91
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
43,711.29
|
40,847.57
|
35,068.56
|
37,921.02
|
37,341.33
|
32,093.59
|
|
|
|
|
|
|
Current Assets
|
63,860.29
|
63,860.29
|
52,594.06
|
43,433.11
|
39,861.94
|
34,864.60
|
|
|
|
|
|
|
Total Assets
|
1,08,785.22
|
1,08,407.20
|
91,908.14
|
85,327.79
|
80,711.90
|
69,775.91
|
|
|
|
|
|
|
Total Debt*
|
--
|
4,081.61
|
1,869.63
|
2,845.69
|
6,197.88
|
930.69
|
|
|
|
|
|
|
Net Current Assets
|
41,238.25
|
41,238.25
|
34,399.85
|
26,449.34
|
19,955.56
|
17,656.15
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
1,587.05
|
4,276.02
|
4,567.19
|
4,061.31
|
3,647.11
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
12,419.18
|
14,072.09
|
12,134.98
|
4,959.33
|
8,984.54
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-11,344.05
|
-5,306.16
|
-690.20
|
-7,943.68
|
-5,724.74
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-2,512.55
|
-7,905.82
|
-6,710.16
|
2,376.07
|
-5,193.46
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-1,437.42
|
860.11
|
4,734.62
|
-608.28
|
-1,933.66
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
52.64
|
47.84
|
45.55
|
39.91
|
35.32
|
13.64
|
|
|
|
|
|
|
Cash EPS (₹)
|
50.41
|
60.44
|
56.50
|
50.87
|
46.22
|
23.13
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
360.44
|
348.31
|
301.00
|
265.36
|
233.38
|
200.11
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.84
|
16.00
|
16.00
|
13.50
|
11.50
|
10.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
51.76
|
58.65
|
50.58
|
20.67
|
37.45
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
40.12
|
46.28
|
46.12
|
13.93
|
23.40
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
19.11
|
19.89
|
17.60
|
17.24
|
9.28
|
|
|
|
|
|
|
ROE (%)
|
15.65
|
14.85
|
16.16
|
16.13
|
16.46
|
7.21
|
|
|
|
|
|
|
ROA (%)
|
12.12
|
12.02
|
12.99
|
12.17
|
11.88
|
5.20
|
|
|
|
|
|
|
EBIT Margin (%)
|
23.85
|
23.18
|
23.79
|
21.02
|
20.64
|
20.02
|
|
|
|
|
|
|
Net Margin (%)
|
19.41
|
18.75
|
20.06
|
19.25
|
19.20
|
8.50
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
24.81
|
25.78
|
25.17
|
25.27
|
8.26
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
11.41
|
11.19
|
8.42
|
10.51
|
13.53
|
15.39
|
|
|
|
|
|
|
EBIT Growth (%)
|
8.10
|
8.33
|
22.75
|
12.52
|
17.06
|
21.14
|
|
|
|
|
|
|
Net Profit Growth (%)
|
10.18
|
5.32
|
13.80
|
12.70
|
151.36
|
49.07
|
|
|
|
|
|
|
EPS Growth (%)
|
16.62
|
5.04
|
14.13
|
13.01
|
158.91
|
12.70
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
15.72
|
13.43
|
13.70
|
16.63
|
3.33
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
37.67
|
36.73
|
38.10
|
40.60
|
27.84
|
67.07
|
|
|
|
|
|
|
Price / Book Value
|
5.27
|
5.05
|
5.77
|
6.11
|
4.21
|
4.57
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.84
|
0.91
|
0.92
|
0.83
|
1.17
|
1.09
|
|
|
|
|
|
|
EV/EBITDA
|
22.32
|
21.02
|
23.61
|
26.51
|
19.24
|
19.03
|
|
|
|
|
|
|
Close Price (₹)
|
1,862.50
|
1,757.20
|
1,734.70
|
1,620.55
|
983.10
|
914.75
|
|
|
|
|
|
|
High Price (₹)
|
1,917.15
|
1,851.20
|
1,960.35
|
1,634.05
|
1,072.15
|
931.00
|
|
|
|
|
|
|
Low Price (₹)
|
1,547.25
|
1,547.25
|
1,376.75
|
922.45
|
789.75
|
592.60
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
4,55,633.71
|
4,21,639.92
|
4,16,384.44
|
3,88,808.95
|
2,35,876.75
|
2,19,487.96
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.00
|
0.05
|
0.03
|
0.04
|
0.11
|
0.02
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.05
|
0.03
|
0.04
|
0.11
|
0.01
|
|
|
|
|
|
|
Current Ratio
|
2.82
|
2.82
|
2.89
|
2.56
|
2.00
|
2.03
|
|
|
|
|
|
|
Quick Ratio
|
2.31
|
2.31
|
2.33
|
1.98
|
1.47
|
1.51
|
|
|
|
|
|
|
Interest Coverage
|
45.11
|
45.61
|
60.44
|
47.50
|
55.70
|
36.19
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
25.89
|
26.53
|
24.81
|
23.20
|
26.06
|
27.12
|
|
|
|
|
|
|
Asset Turnover
|
0.60
|
0.61
|
0.62
|
0.61
|
0.61
|
1.03
|
|
|
|
|
|
|
Receivable days
|
--
|
89.14
|
84.33
|
85.38
|
91.17
|
53.09
|
|
|
|
|
|
|
Inventory Days
|
--
|
67.85
|
69.81
|
76.70
|
80.83
|
48.68
|
|
|
|
|
|
|
Payable days
|
--
|
213.72
|
201.01
|
194.01
|
174.10
|
149.21
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-56.72
|
-46.88
|
-31.93
|
-2.10
|
-47.44
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
